First Clinical Trials Started in Israel

January 12, 2017

 

Alpha Tau Medical has initiated its first clinical trials with its Alpha DaRT (Diffusing Alpha–emitters Radiation Therapy) technology for the treatment of Squamous Cell Carcinoma (SCC) in Head, Neck and Skin at the Rabin Medical Center, Petah Tikva outside Tel Aviv.
The company is in the process of starting additional clinical trials in prostate cancer, breast cancer, colorectal cancer, gynecological cancer and pancreatic cancer.
The Alpha DaRT technology enables the possibility of providing brachytherapy treatment based on alpha emitters and has several advantages:
1.    Highly Potent and Ultra conformal
2.    Effective regardless of tumor oxygen level
3.    Short half-life – quick clinical results
4.    Negligible gamma radiation, no special shielding equipment is needed
5.    Disposable product – not capital equipment is needed
To keep up to date on our progress in the clinical trials, please follow us on LinkedIn, Twitter  or subscribe to our newsletter.

 

 

 

 

Share on Facebook
Share on Twitter
Please reload

Please reload

Featured Posts

Israel's alpha radiation treatment shows tumor shrinkage in 100% of cases

1/6
Please reload

Archive
Please reload

Categories
Follow Us
  • Grey Facebook Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon
  • Grey Facebook Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon

Looking for clinical trials?